STOCK TITAN

[Form 4] Enhabit, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Stuart M. McGuigan, a director of Enhabit, Inc. (EHAB), reported a purchase of 2,344 shares of the company's common stock on 10/10/2025 at a price of $8 per share. After the transaction he beneficially owns 72,245 shares. The Form 4 was filed as a single reporting person filing and signed by an attorney-in-fact, Sarah W. Braley, on 10/10/2025. The filing discloses a routine insider purchase by a board member with no derivative transactions reported.

Stuart M. McGuigan, direttore di Enhabit, Inc. (EHAB), ha riferito l'acquisto di 2.344 azioni ordinarie della società il 10/10/2025 al prezzo di $8 per azione. Dopo la transazione detiene 72.245 azioni in titolarità beneficiaria. Il Modulo 4 è stato presentato come presentazione da parte di un unico soggetto dichiarante e firmato da un procuratore-in-fact, Sarah W. Braley, il 10/10/2025. La presentazione riferisce un acquisto di insider di routine da parte di un membro del consiglio senza transazioni derivate riportate.

Stuart M. McGuigan, un director de Enhabit, Inc. (EHAB), comunicó la compra de 2.344 acciones ordinarias de la compañía el 10/10/2025 a un precio de $8 por acción. Después de la transacción posee 72.245 acciones. El Formulario 4 fue presentado como una única persona declarando y firmado por un apoderado, Sarah W. Braley, el 10/10/2025. El documento divulga una compra de insider de rutina por parte de un miembro de la junta sin transacciones derivadas reportadas.

Stuart M. McGuigan은 Enhabit, Inc.(EHAB)의 이사로서 2025년 10월 10일(10/10/2025)에 회사의 보통주 2,344주를 주당 $8의 가격으로 매입했다고 보고했습니다. 거래 후 그는 72,245주를 유익하게 소유하고 있습니다. Form 4는 단일 보고자 제출로 작성되었고, Sarah W. Braley라는 법정 대리인이 10/10/2025에 서명했습니다. 이 제출은 이사회 구성원의 일상적인 내부자 매매를 공개하지만 파생거래는 보고되지 않았음을 밝힙니다.

Stuart M. McGuigan, directeur de Enhabit, Inc. (EHAB), a signalé l'achat de 2 344 actions ordinaires de la société le 10/10/2025 au prix de $8 par action. Après la transaction, il détient 72 245 actions en propriété bénéficiaire. Le Formulaire 4 a été déposé comme une seule personne déclarant et signé par un mandataire, Sarah W. Braley, le 10/10/2025. Le dépôt divulgue un achat d'initié de routine par un membre du conseil sans transactions dérivées signalées.

Stuart M. McGuigan, Direktor von Enhabit, Inc. (EHAB), hat den Kauf von 2.344 Aktien der Stammaktien des Unternehmens am 10/10/2025 zu einem Preis von $8 pro Aktie gemeldet. Nach der Transaktion besitzt er benefitär 72.245 Aktien. Das Formular 4 wurde als Einzeltätermeldung eingereicht und von einer Bevollmächtigten, Sarah W. Braley, am 10/10/2025 unterschrieben. Die Einreichung offenbart einen routinemäßigen Insiderkauf durch ein Vorstandsmitglied ohne berichtete Derivategeschäfte.

Stuart M. McGuigan، المدير في Enhabit, Inc. (EHAB)، أبلغ عن شراء 2,344 سهماً من أسهم الشركة العادية في 10/10/2025 بسعر $8 للسهم. بعد الصفقة يمتلك فائدة 72,245 سهماً. تم تقديم النموذج 4 كإبلاغ من شخص واحد وتوقيعه من قبل وكيل قانوني، Sarah W. Braley، في 10/10/2025. يُظهر الإبلاغ شراءInsider روتيني من قبل عضو مجلس الإدارة بدون معاملات مشتقة مذكورة.

Stuart M. McGuigan董事,Enhabit, Inc.(EHAB)的< b>报告人?

Positive
  • Director purchase of 2,344 shares at $8 shows personal investment alignment
  • Beneficial ownership increased to 72,245 shares, reinforcing insider stake
Negative
  • Transaction size is modest and unlikely to be materially impactful to valuation
  • No derivative activity reported, limiting insight into broader compensation or hedging

Insights

Director purchase increases insider stake modestly; signals alignment with shareholders.

The reported acquisition of 2,344 shares at $8 increases the director's total beneficial ownership to 72,245 shares. Director purchases are commonly viewed as a sign of confidence because they place personal capital at risk alongside other shareholders.

Reliance on this single transaction is limited; its investor impact is modest relative to total market cap. Watch for additional filings or patterned purchases over the next 6-12 months to assess whether this reflects a sustained insider accumulation strategy.

Transaction size is small but reduces potential information asymmetry.

A 2,344-share open-market buy at $8 is a straightforward non-derivative acquisition that does not change control or trigger material disclosure thresholds. It increases the director's direct stake and provides a clear, recorded price point for this insider.

Material implications are limited absent larger purchases or timed trades around corporate events; monitor subsequent Form 4s and quarterly disclosures for cumulative insider activity within 3-12 months.

Stuart M. McGuigan, direttore di Enhabit, Inc. (EHAB), ha riferito l'acquisto di 2.344 azioni ordinarie della società il 10/10/2025 al prezzo di $8 per azione. Dopo la transazione detiene 72.245 azioni in titolarità beneficiaria. Il Modulo 4 è stato presentato come presentazione da parte di un unico soggetto dichiarante e firmato da un procuratore-in-fact, Sarah W. Braley, il 10/10/2025. La presentazione riferisce un acquisto di insider di routine da parte di un membro del consiglio senza transazioni derivate riportate.

Stuart M. McGuigan, un director de Enhabit, Inc. (EHAB), comunicó la compra de 2.344 acciones ordinarias de la compañía el 10/10/2025 a un precio de $8 por acción. Después de la transacción posee 72.245 acciones. El Formulario 4 fue presentado como una única persona declarando y firmado por un apoderado, Sarah W. Braley, el 10/10/2025. El documento divulga una compra de insider de rutina por parte de un miembro de la junta sin transacciones derivadas reportadas.

Stuart M. McGuigan은 Enhabit, Inc.(EHAB)의 이사로서 2025년 10월 10일(10/10/2025)에 회사의 보통주 2,344주를 주당 $8의 가격으로 매입했다고 보고했습니다. 거래 후 그는 72,245주를 유익하게 소유하고 있습니다. Form 4는 단일 보고자 제출로 작성되었고, Sarah W. Braley라는 법정 대리인이 10/10/2025에 서명했습니다. 이 제출은 이사회 구성원의 일상적인 내부자 매매를 공개하지만 파생거래는 보고되지 않았음을 밝힙니다.

Stuart M. McGuigan, directeur de Enhabit, Inc. (EHAB), a signalé l'achat de 2 344 actions ordinaires de la société le 10/10/2025 au prix de $8 par action. Après la transaction, il détient 72 245 actions en propriété bénéficiaire. Le Formulaire 4 a été déposé comme une seule personne déclarant et signé par un mandataire, Sarah W. Braley, le 10/10/2025. Le dépôt divulgue un achat d'initié de routine par un membre du conseil sans transactions dérivées signalées.

Stuart M. McGuigan, Direktor von Enhabit, Inc. (EHAB), hat den Kauf von 2.344 Aktien der Stammaktien des Unternehmens am 10/10/2025 zu einem Preis von $8 pro Aktie gemeldet. Nach der Transaktion besitzt er benefitär 72.245 Aktien. Das Formular 4 wurde als Einzeltätermeldung eingereicht und von einer Bevollmächtigten, Sarah W. Braley, am 10/10/2025 unterschrieben. Die Einreichung offenbart einen routinemäßigen Insiderkauf durch ein Vorstandsmitglied ohne berichtete Derivategeschäfte.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MCGUIGAN STUART M

(Last) (First) (Middle)
6688 N. CENTRAL EXPRESSWAY, SUITE 1300

(Street)
DALLAS TX 75206

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enhabit, Inc. [ EHAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/10/2025 A 2,344 A $8 72,245 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Sarah W. Braley, Attorney in Fact 10/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Enhabit (EHAB) director Stuart McGuigan purchase on 10/10/2025?

He purchased 2,344 shares of common stock at $8 per share on 10/10/2025.

How many Enhabit (EHAB) shares does Stuart McGuigan own after the transaction?

He beneficially owns 72,245 shares following the reported purchase.

Was the Form 4 for this transaction filed jointly or by one person?

The Form 4 was filed by one reporting person (individual filing).

Who signed the Form 4 for Stuart McGuigan's transaction?

The form was signed by attorney-in-fact Sarah W. Braley on 10/10/2025.

Did the filing disclose any option or derivative transactions for EHAB?

No; the filing shows only a non-derivative common stock purchase and lists no derivative transactions.
Enhabit

NYSE:EHAB

EHAB Rankings

EHAB Latest News

EHAB Latest SEC Filings

EHAB Stock Data

405.52M
48.91M
3.4%
102.87%
3.26%
Medical Care Facilities
Services-home Health Care Services
Link
United States
DALLAS